| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.0087 | 1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |